INNOVIVA, INC. Increase (Decrease) in Due from Related Parties, Current
INNOVIVA, INC. (INVA) reported Increase (Decrease) in Due from Related Parties, Current of -$2.62 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueFromRelatedPartiesCurrent · last filed 2025-11-05
- INNOVIVA, INC. increase (decrease) in due from related parties, current for the quarter ending 2025-09-30 was -$3.98M.
- INNOVIVA, INC. increase (decrease) in due from related parties, current for the quarter ending 2025-06-30 was $6.07M, a 14.00% increase year-over-year.
- INNOVIVA, INC. increase (decrease) in due from related parties, current for the quarter ending 2025-03-31 was -$4.71M.
- INNOVIVA, INC. increase (decrease) in due from related parties, current for the quarter ending 2024-12-31 was $5.46M, a 56.68% decline year-over-year.
- INNOVIVA, INC. increase (decrease) in due from related parties, current for fiscal 2024 was -$3.65M, a 124.40% decline from fiscal 2023.
- INNOVIVA, INC. increase (decrease) in due from related parties, current for fiscal 2023 was $14.95M.
- INNOVIVA, INC. increase (decrease) in due from related parties, current for fiscal 2022 was -$13.32M, a 179.37% decline from fiscal 2021.
- INNOVIVA, INC. increase (decrease) in due from related parties, current for fiscal 2021 was $16.78M, a 15.69% increase from fiscal 2020.
| Period end | Increase (Decrease) in Due from Related Parties, Current 3 month | Increase (Decrease) in Due from Related Parties, Current 6 month | Increase (Decrease) in Due from Related Parties, Current 9 month | Increase (Decrease) in Due from Related Parties, Current 12 month |
|---|---|---|---|---|
| 2025-09-30 | -$3.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $2.09M derived: sum of 2 quarters · filed 2025-11-05 | -$2.62M 10-Q · filed 2025-11-05 | $2.84M derived: sum of 4 quarters · filed 2025-11-05 |
| 2025-06-30 | $6.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $1.36M 10-Q · filed 2025-08-06 | $6.82M derived: sum of 3 quarters · filed 2025-08-06 | $138.00K derived: sum of 4 quarters · filed 2025-11-05 |
| 2025-03-31 | -$4.71M 10-Q · filed 2025-05-07 | $751.00K derived: sum of 2 quarters · filed 2025-05-07 | -$5.93M derived: sum of 3 quarters · filed 2025-11-05 | -$608.00K derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-12-31 | $5.46M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$1.22M derived: sum of 2 quarters · filed 2025-11-05 | $4.10M derived: sum of 3 quarters · filed 2025-11-05 | -$3.65M 10-K · filed 2025-02-26 |
| 2024-09-30 | -$6.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$1.36M derived: sum of 2 quarters · filed 2025-11-05 | -$9.11M 10-Q · filed 2025-11-05 | $3.50M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $5.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$2.42M 10-Q · filed 2025-08-06 | $10.19M derived: sum of 3 quarters · filed 2025-08-06 | $1.48M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | -$7.75M 10-Q · filed 2025-05-07 | $4.86M derived: sum of 2 quarters · filed 2025-05-07 | -$3.85M derived: sum of 3 quarters · filed 2025-05-07 | $1.56M derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | $12.61M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $3.90M derived: sum of 2 quarters · filed 2025-02-26 | $9.31M derived: sum of 3 quarters · filed 2025-02-26 | $14.95M 10-K · filed 2025-02-26 |
| 2023-09-30 | -$8.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | -$3.30M derived: sum of 2 quarters · filed 2024-07-31 | $2.34M 10-Q · filed 2023-11-01 | -$8.59M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $5.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $11.05M 10-Q · filed 2024-07-31 | $115.00K derived: sum of 3 quarters · filed 2025-02-26 | -$3.23M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $5.64M 10-Q · filed 2024-05-08 | -$5.29M derived: sum of 2 quarters · filed 2025-02-26 | -$8.64M derived: sum of 3 quarters · filed 2025-02-26 | $9.52M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | -$10.93M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$14.28M derived: sum of 2 quarters · filed 2025-02-26 | $3.88M derived: sum of 3 quarters · filed 2025-02-26 | -$13.32M 10-K · filed 2025-02-26 |
| 2022-09-30 | -$3.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $14.81M derived: sum of 2 quarters · filed 2023-11-01 | -$2.38M 10-Q · filed 2023-11-01 | $7.05M derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-06-30 | $18.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $965.00K 10-Q · filed 2023-08-02 | $10.40M derived: sum of 3 quarters · filed 2024-03-05 | $7.41M derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-03-31 | -$17.20M 10-Q · filed 2023-05-09 | -$7.76M derived: sum of 2 quarters · filed 2024-03-05 | -$10.75M derived: sum of 3 quarters · filed 2024-03-05 | $4.54M derived: sum of 4 quarters · filed 2024-03-05 |
| 2021-12-31 | $9.44M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-03-05 | $6.45M derived: sum of 2 quarters · filed 2024-03-05 | $21.74M derived: sum of 3 quarters · filed 2024-03-05 | $16.78M 10-K/A · filed 2024-03-05 |
| 2021-09-30 | -$2.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $12.30M derived: sum of 2 quarters · filed 2022-11-09 | $7.34M 10-Q · filed 2022-11-09 | $9.12M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $15.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | $10.33M 10-Q · filed 2022-07-27 | $12.11M derived: sum of 3 quarters · filed 2023-02-28 | $21.86M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$4.96M 10-Q · filed 2022-05-05 | -$3.18M derived: sum of 2 quarters · filed 2023-02-28 | $6.57M derived: sum of 3 quarters · filed 2023-02-28 | $6.84M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $11.53M derived: sum of 2 quarters · filed 2023-02-28 | $11.80M derived: sum of 3 quarters · filed 2023-02-28 | $14.50M 10-K · filed 2023-02-28 |
| 2020-09-30 | $9.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27 | $10.02M derived: sum of 2 quarters · filed 2021-10-27 | $12.72M 10-Q · filed 2021-10-27 | $22.94M derived: sum of 4 quarters · filed 2022-03-17 |
| 2020-06-30 | $268.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $2.98M 10-Q · filed 2021-07-29 | $13.19M derived: sum of 3 quarters · filed 2022-03-17 | $14.84M derived: sum of 4 quarters · filed 2022-03-17 |
| 2020-03-31 | $2.71M 10-Q · filed 2021-04-28 | $12.92M derived: sum of 2 quarters · filed 2022-03-17 | $14.57M derived: sum of 3 quarters · filed 2022-03-17 | $23.50M derived: sum of 4 quarters · filed 2022-03-17 |
| 2019-12-31 | $10.22M derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-03-17 | $11.86M derived: sum of 2 quarters · filed 2022-03-17 | $20.79M derived: sum of 3 quarters · filed 2022-03-17 | -$3.86M 10-K/A · filed 2022-03-17 |
| 2019-09-30 | $1.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-28 | $10.57M derived: sum of 2 quarters · filed 2020-10-28 | -$14.07M 10-Q · filed 2020-10-28 | $4.08M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $8.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | -$15.72M 10-Q · filed 2020-07-29 | $2.43M derived: sum of 3 quarters · filed 2021-02-25 | -$2.98M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | -$24.65M 10-Q · filed 2020-04-29 | -$6.50M derived: sum of 2 quarters · filed 2021-02-25 | -$11.90M derived: sum of 3 quarters · filed 2021-02-25 | $2.80M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $18.15M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $12.74M derived: sum of 2 quarters · filed 2021-02-25 | $27.45M derived: sum of 3 quarters · filed 2021-02-25 | $12.75M 10-K · filed 2021-02-25 |
| 2018-09-30 | -$5.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $9.30M derived: sum of 2 quarters · filed 2019-10-30 | -$5.40M 10-Q · filed 2019-10-30 | $13.26M derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-06-30 | $14.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | $2.00K 10-Q · filed 2019-07-24 | $18.66M derived: sum of 3 quarters · filed 2020-02-19 | $8.75M derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-03-31 | -$14.71M 10-Q · filed 2019-05-01 | $3.96M derived: sum of 2 quarters · filed 2020-02-19 | -$5.96M derived: sum of 3 quarters · filed 2020-02-19 | $12.11M derived: sum of 4 quarters · filed 2020-02-19 |
| 2017-12-31 | $18.66M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $8.74M derived: sum of 2 quarters · filed 2020-02-19 | $26.81M derived: sum of 3 quarters · filed 2020-02-19 | $23.69M 10-K · filed 2020-02-19 |
| 2017-09-30 | -$9.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $8.15M derived: sum of 2 quarters · filed 2018-10-31 | $5.03M 10-Q · filed 2018-10-31 | $15.26M derived: sum of 4 quarters · filed 2019-02-19 |
| 2017-06-30 | $18.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | $14.95M 10-Q · filed 2018-07-26 | $25.18M derived: sum of 3 quarters · filed 2019-02-19 | $25.98M derived: sum of 4 quarters · filed 2019-02-19 |
| 2017-03-31 | -$3.12M 10-Q · filed 2018-05-04 | $7.11M derived: sum of 2 quarters · filed 2019-02-19 | $7.91M derived: sum of 3 quarters · filed 2019-02-19 | $16.19M derived: sum of 4 quarters · filed 2019-02-19 |
| 2016-12-31 | $10.23M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | $11.03M derived: sum of 2 quarters · filed 2019-02-19 | $19.31M derived: sum of 3 quarters · filed 2019-02-19 | $20.62M 10-K · filed 2019-02-19 |
| 2016-09-30 | $804.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $9.08M derived: sum of 2 quarters · filed 2017-11-03 | $10.39M 10-Q · filed 2017-11-03 | $19.67M derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-06-30 | $8.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $9.59M 10-Q · filed 2017-08-08 | $18.87M derived: sum of 3 quarters · filed 2018-02-23 | $21.82M derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-03-31 | $1.31M 10-Q · filed 2017-05-05 | $10.59M derived: sum of 2 quarters · filed 2018-02-23 | $13.54M derived: sum of 3 quarters · filed 2018-02-23 | $17.30M derived: sum of 4 quarters · filed 2018-02-23 |
| 2015-12-31 | $9.28M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $12.23M derived: sum of 2 quarters · filed 2018-02-23 | $15.99M derived: sum of 3 quarters · filed 2018-02-23 | $15.68M 10-K · filed 2018-02-23 |
| 2015-09-30 | $2.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $6.71M derived: sum of 2 quarters · filed 2016-11-03 | $6.40M 10-Q · filed 2016-11-03 | |
| 2015-06-30 | $3.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $3.45M 10-Q · filed 2016-08-04 | ||
| 2015-03-31 | -$311.00K 10-Q · filed 2016-05-05 | |||
| 2014-12-31 | $7.37M 10-K · filed 2017-02-28 | |||
| 2013-12-31 | $2.12M 10-K · filed 2016-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |